TIQUIZIUM: 17 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
17
Total FAERS Reports
1 (5.9%)
Deaths Reported
10
Hospitalizations
17
As Primary/Secondary Suspect
Active Ingredient: TIQUIZIUM BROMIDE ·
First Report: 2002 · Latest Report: 20161029
What Are the Most Common TIQUIZIUM Side Effects?
#1 Most Reported
Drug hypersensitivity
8 reports (47.1%)
#2 Most Reported
Abdominal discomfort
8 reports (47.1%)
#3 Most Reported
Intentional product misuse
7 reports (41.2%)
All TIQUIZIUM Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Abdominal discomfort | 8 | 47.1% | 0 | 2 |
| Drug hypersensitivity | 8 | 47.1% | 0 | 2 |
| Intentional product misuse | 7 | 41.2% | 0 | 1 |
| Arthritis | 6 | 35.3% | 0 | 0 |
| Barrett's oesophagus | 6 | 35.3% | 0 | 0 |
| Bladder disorder | 6 | 35.3% | 0 | 0 |
| Blood magnesium decreased | 6 | 35.3% | 0 | 0 |
| Blood zinc decreased | 6 | 35.3% | 0 | 0 |
| Condition aggravated | 6 | 35.3% | 0 | 0 |
| Cystitis | 6 | 35.3% | 0 | 0 |
| Diabetes mellitus | 6 | 35.3% | 0 | 0 |
| Drug ineffective | 6 | 35.3% | 0 | 0 |
| Fatigue | 6 | 35.3% | 0 | 0 |
| Femur fracture | 6 | 35.3% | 0 | 0 |
| Micturition urgency | 6 | 35.3% | 0 | 0 |
| Rash macular | 6 | 35.3% | 0 | 0 |
| Sleep disorder due to a general medical condition | 6 | 35.3% | 0 | 0 |
| Product physical issue | 5 | 29.4% | 0 | 0 |
Who Reports TIQUIZIUM Side Effects? Age & Gender Data
Gender: 75.0% female, 25.0% male. Average age: 56.0 years. Most reports from: JP. View detailed demographics →
Is TIQUIZIUM Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2002 | 3 | 0 | 0 |
| 2004 | 3 | 0 | 0 |
| 2013 | 2 | 0 | 2 |
| 2015 | 1 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
What Is TIQUIZIUM Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 8 |
Official FDA Label for TIQUIZIUM
Official prescribing information from the FDA-approved drug label.